JT

Jerry Andrew Taylor

Merck: 8 patents #1,412 of 9,382Top 20%
LP Lexicon Pharmaceuticals: 2 patents #68 of 138Top 50%
EG Elexopharm Gmbh: 1 patents #11 of 27Top 45%
EL Eli Lilly: 1 patents #1,742 of 2,858Top 65%
Overall (All Time): #453,362 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11014920 Factor XIIa inhibitors Jacqueline D. Hicks, Brian McKittrick, Brent Whitehead, Matthew Lombardo, Xiaoqing Han +4 more 2021-05-25
11008313 Substituted 1-methyl-1,2,3,4-tetrahydroisoquinoline molecules as PCSK9 allosteric binders Jason Imbriglio, Whitney Lane Petrilli, Yusheng Xiong, Zhe Feng, Hyewon Youm +4 more 2021-05-18
10875851 Factor XIIa inhibitors Ashwin U. Rao, Brian McKittrick, Matthew Lombardo, Jacqueline D. Hicks, Amy Bittner McCracken +12 more 2020-12-29
9567333 Triazolopyridyl compounds as aldosterone synthase inhibitors D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke, Scott B. Hoyt +6 more 2017-02-14
9522141 Indazole compounds as aldosterone synthase inhibitors Scott B. Hoyt, Clare London, Yusheng Xiong, Andrew Cooke 2016-12-20
9518055 Imidazopyridyl compounds as aldosterone synthase inhibitors Amjad Ali, D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke +8 more 2016-12-13
9193724 Triazolopyridyl compounds as aldosterone synthase inhibitors D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke, Scott B. Hoyt +6 more 2015-11-24
9073929 Aldosterone synthase inhibitors Scott B. Hoyt, Whitney Lane Petrilli, Clare London, Yusheng Xiong, Amjad Ali +10 more 2015-07-07
8093245 4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use David J. Augeri, Marianne Carlsen, Kenneth G. Carson, Qinghong Fu, Alexander Heim-Riether +2 more 2012-01-10
8093246 O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer David J. Augeri, Marianne Carlsen, Kenneth G. Carson, Qinghong Fu, Jason Healy +6 more 2012-01-10
6821951 Processes for making pharmaceutical oral ECB formulations and compositions John Richard Schwier 2004-11-23